Myelodysplastic Syndrome (MDS) Information Center
Myelodysplastic syndromes (MDS) are a group of diseases marked by abnormal production of blood cells by the bone marrow.
An estimated one-third of patients with myelodysplastic syndromes will have their disease progress to acute myeloid leukemia (AML). AML that develops from myelodysplastic syndromes tends to be difficult to treat. Fortunately, advances in chemotherapy and stem cell transplantation are improving outcomes among patients with myelodysplastic syndromes. In addition, advances in supportive care allow symptoms of myelodysplastic syndromes to be effectively managed, leading to improved quality of life.
Understanding treatment options for myelodysplastic syndromes, the role of different doctors specializing in the treatment of myelodysplastic syndromes, and how and when to access new and innovative treatment options available through clinical trials is essential in order to achieve the best outcome from treatment of myelodysplastic syndromes.
The Cancer Consultants Myelodysplastic Syndrome Information Center has been designed to help patients understand myelodysplastic syndromes and treatment options for myelodysplastic syndromes while providing ongoing information, inspiration, support, and community to individuals affected by a diagnosis of myelodysplastic syndrome.
Headline MDS News 
Approximately 16% of Worldwide Cancers Caused By Preventable Infections
About 16% of cancers worldwide are the result of preventable and treatable infections.
Aspirin Continues to Look Promising for Cancer Prevention
Study reports fewer cases and fewer deaths with daily use.
CancerConnect Live Web Chat with Dr. Barrie Cassileth from Memorial Sloan-Kettering Cancer Center on Complementary Cancer Therapies on Thursday, November 17th at 6PM EST
Live Web Chat with Barrie R. Cassileth, PhD, Chief, Integrative Medicine Service;...
Myelodysplastic Syndrome Tips
Men, Fertility, and Cancer Men who confront a cancer diagnosis before beginning or completing their families...
Women, Fertility and Cancer Women who confront a cancer diagnosis before beginning or completing their families...
What is Genomics? You’ve probably heard of genetic testing for cancer susceptibility, but the more...
Myelodysplastic Syndrome Management
Inspiration, Hope & Resources
On Top of the World: Climbing Everest & Beating Cancer Twice Sean Swarner is a master of setting a goal and achieving it. So when he...
Jack & Jill Late Stage Cancer Foundation Jon Albert, founder of the Jack & Jill Late Stage Cancer Foundation shows the...
Moving Bodies, Changing Lives Moving On Aerobics helps women regain joy of movement and physical fitness after...
Myelodysplastic Syndrome Clinical Trials
ECOGE1905 – A Randomized Phase II Trial of Azacitidine with or without the Histone Deacetylase Inhibitor MS-275 for the Treatment of Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia (dysplastic type), and Acute Myeloid Leukemia with Multilineage Dysplasia.
DACO-020 – Phase 2 study of Decitabine Administered Daily for 5 Days Every 4 Weeks to Adults with Advanced-Stage Myelodysplastic Syndromes
REFMAL39 – A Phase I, Open-Label, Dose-Escalation Study of SB-715992 Administered Weekly for Three Consecutive Weeks of 28-Day Cycle in Patients with Solid Tumors
 |
 |
 |
 |
